380 related articles for article (PubMed ID: 28196595)
1. Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.
Li J; Zhao W; Akbani R; Liu W; Ju Z; Ling S; Vellano CP; Roebuck P; Yu Q; Eterovic AK; Byers LA; Davies MA; Deng W; Gopal YN; Chen G; von Euw EM; Slamon D; Conklin D; Heymach JV; Gazdar AF; Minna JD; Myers JN; Lu Y; Mills GB; Liang H
Cancer Cell; 2017 Feb; 31(2):225-239. PubMed ID: 28196595
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
[TBL] [Abstract][Full Text] [Related]
3. Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.
Zhao W; Li J; Chen MM; Luo Y; Ju Z; Nesser NK; Johnson-Camacho K; Boniface CT; Lawrence Y; Pande NT; Davies MA; Herlyn M; Muranen T; Zervantonakis IK; von Euw E; Schultz A; Kumar SV; Korkut A; Spellman PT; Akbani R; Slamon DJ; Gray JW; Brugge JS; Lu Y; Mills GB; Liang H
Cancer Cell; 2020 Dec; 38(6):829-843.e4. PubMed ID: 33157050
[TBL] [Abstract][Full Text] [Related]
4. Reverse phase protein arrays in signaling pathways: a data integration perspective.
Creighton CJ; Huang S
Drug Des Devel Ther; 2015; 9():3519-27. PubMed ID: 26185419
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
Berg KCG; Eide PW; Eilertsen IA; Johannessen B; Bruun J; Danielsen SA; Bjørnslett M; Meza-Zepeda LA; Eknæs M; Lind GE; Myklebost O; Skotheim RI; Sveen A; Lothe RA
Mol Cancer; 2017 Jul; 16(1):116. PubMed ID: 28683746
[TBL] [Abstract][Full Text] [Related]
6. Profiling activities of transcription factors in breast cancer cell lines.
Jiang X; Roth L; Lai C; Li X
Assay Drug Dev Technol; 2006 Jun; 4(3):293-305. PubMed ID: 16834535
[TBL] [Abstract][Full Text] [Related]
7. Integration of pan-cancer transcriptomics with RPPA proteomics reveals mechanisms of epithelial-mesenchymal transition.
Koplev S; Lin K; Dohlman AB; Ma'ayan A
PLoS Comput Biol; 2018 Jan; 14(1):e1005911. PubMed ID: 29293502
[TBL] [Abstract][Full Text] [Related]
8. Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.
Coco S; Truini A; Alama A; Dal Bello MG; Venè R; Garuti A; Carminati E; Rijavec E; Genova C; Barletta G; Sini C; Ballestrero A; Boccardo F; Grossi F
Target Oncol; 2015 Sep; 10(3):393-404. PubMed ID: 25341405
[TBL] [Abstract][Full Text] [Related]
9. Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.
Li J; Akbani R; Zhao W; Lu Y; Weinstein JN; Mills GB; Liang H
Cancer Res; 2017 Nov; 77(21):e51-e54. PubMed ID: 29092939
[TBL] [Abstract][Full Text] [Related]
10. Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.
Mendes KN; Nicorici D; Cogdell D; Tabus I; Yli-Harja O; Guerra R; Hamilton SR; Zhang W
J Proteome Res; 2007 Jul; 6(7):2753-67. PubMed ID: 17564428
[TBL] [Abstract][Full Text] [Related]
11. Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein Arrays.
Chen MM; Li J; Mills GB; Liang H
JCO Clin Cancer Inform; 2020 Apr; 4():357-366. PubMed ID: 32330068
[TBL] [Abstract][Full Text] [Related]
12. Reverse phase protein arrays: mapping the path towards personalized medicine.
Gallagher RI; Espina V
Mol Diagn Ther; 2014 Dec; 18(6):619-30. PubMed ID: 25358623
[TBL] [Abstract][Full Text] [Related]
13. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
Suda K; Tomizawa K; Fujii M; Murakami H; Osada H; Maehara Y; Yatabe Y; Sekido Y; Mitsudomi T
J Thorac Oncol; 2011 Jul; 6(7):1152-61. PubMed ID: 21597390
[TBL] [Abstract][Full Text] [Related]
14. Protein Array-based Approaches for Biomarker Discovery in Cancer.
Huang Y; Zhu H
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):73-81. PubMed ID: 28392481
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.
Nishizuka S; Charboneau L; Young L; Major S; Reinhold WC; Waltham M; Kouros-Mehr H; Bussey KJ; Lee JK; Espina V; Munson PJ; Petricoin E; Liotta LA; Weinstein JN
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14229-34. PubMed ID: 14623978
[TBL] [Abstract][Full Text] [Related]
16. Reverse phase protein microarrays for theranostics and patient-tailored therapy.
Espina V; Wulfkuhle J; Calvert VS; Liotta LA; Petricoin EF
Methods Mol Biol; 2008; 441():113-28. PubMed ID: 18370315
[TBL] [Abstract][Full Text] [Related]
17. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT).
Sodek KL; Evangelou AI; Ignatchenko A; Agochiya M; Brown TJ; Ringuette MJ; Jurisica I; Kislinger T
Mol Biosyst; 2008 Jul; 4(7):762-73. PubMed ID: 18563251
[TBL] [Abstract][Full Text] [Related]
18. [Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].
Gilabert M; Audebert S; Viens P; Borg JP; Bertucci F; Gonçalves A
Bull Cancer; 2010 Mar; 97(3):321-39. PubMed ID: 20202919
[TBL] [Abstract][Full Text] [Related]
19. Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cells.
Matsubara D; Ishikawa S; Oguni S; Aburatani H; Fukayama M; Niki T
J Thorac Oncol; 2010 Sep; 5(9):1317-24. PubMed ID: 20736805
[TBL] [Abstract][Full Text] [Related]
20. Characterization of signalling pathways by reverse phase protein arrays.
Malinowsky K; Wolff C; Schott C; Becker KF
Methods Mol Biol; 2013; 1049():285-99. PubMed ID: 23913224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
